LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer

Tamoxifen (TAMR) resistance remains a massive obstacle for breast cancer (BC) management. The precise parts of long non-coding RNA ataxin 8 opposite strand (ATXN8OS) in BC TAMR resistance have not been defined.

Bibliographic Details
Main Authors: Zhang Hongkai, Zhang Jianni, Dong Lining, Ma Rong
Format: Article
Language:English
Published: De Gruyter 2020-12-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2021-0012
_version_ 1797998367622561792
author Zhang Hongkai
Zhang Jianni
Dong Lining
Ma Rong
author_facet Zhang Hongkai
Zhang Jianni
Dong Lining
Ma Rong
author_sort Zhang Hongkai
collection DOAJ
description Tamoxifen (TAMR) resistance remains a massive obstacle for breast cancer (BC) management. The precise parts of long non-coding RNA ataxin 8 opposite strand (ATXN8OS) in BC TAMR resistance have not been defined.
first_indexed 2024-04-11T10:47:35Z
format Article
id doaj.art-595a7048e02d4770874b2dacd90dab73
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-04-11T10:47:35Z
publishDate 2020-12-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-595a7048e02d4770874b2dacd90dab732022-12-22T04:29:00ZengDe GruyterOpen Medicine2391-54632020-12-01161688010.1515/med-2021-0012med-2021-0012LncRNA ATXN8OS enhances tamoxifen resistance in breast cancerZhang Hongkai0Zhang Jianni1Dong Lining2Ma Rong3Department of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, ChinaDepartment of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, ChinaDepartment of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, ChinaDepartment of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, ChinaTamoxifen (TAMR) resistance remains a massive obstacle for breast cancer (BC) management. The precise parts of long non-coding RNA ataxin 8 opposite strand (ATXN8OS) in BC TAMR resistance have not been defined.https://doi.org/10.1515/med-2021-0012bcatxn8osmir-16-5pvasptamr resistance
spellingShingle Zhang Hongkai
Zhang Jianni
Dong Lining
Ma Rong
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Open Medicine
bc
atxn8os
mir-16-5p
vasp
tamr resistance
title LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
title_full LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
title_fullStr LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
title_full_unstemmed LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
title_short LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
title_sort lncrna atxn8os enhances tamoxifen resistance in breast cancer
topic bc
atxn8os
mir-16-5p
vasp
tamr resistance
url https://doi.org/10.1515/med-2021-0012
work_keys_str_mv AT zhanghongkai lncrnaatxn8osenhancestamoxifenresistanceinbreastcancer
AT zhangjianni lncrnaatxn8osenhancestamoxifenresistanceinbreastcancer
AT donglining lncrnaatxn8osenhancestamoxifenresistanceinbreastcancer
AT marong lncrnaatxn8osenhancestamoxifenresistanceinbreastcancer